Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences, Inc. (TYRA) scores 38 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is $0.00. Quantitative score: 39/100. Qualitative score: 70/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full TYRA analysis on boothcheck